A microbiota-bile acid-immune axis orchestrates intestinal antiviral defense: CDCA-to-UDCA biotransformation by Limosilactobacillus reuteri LRM2293 is associated with PEDV resistance
BMC Veterinary Research · 2026-09-22 · 22 (1)
DOI: 10.1186/s12917-026-05928-4 ↗At a glance
Journal article in BMC Veterinary Research, published online on 2026-09-22. Written by Ling Sui and 8 co-authors. Institution: College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, China. Major MEDLINE topics: Porcine epidemic diarrhea virus, Coronavirus Infections, Ursodeoxycholic Acid, Swine Diseases. 58 references. The full text is freely available (open access, CC BY 4.0). Funded by: Postdoctoral Fellowship Program and China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (original language)
Porcine epidemic diarrhea virus (PEDV) causes severe intestinal injury and high mortality in neonatal piglets, and effective immunomodulatory strategies remain limited. Here, we investigate a probiotic-derived metabolic axis associated with resistance to PEDV infection through bile acid–immune crosstalk. A Limosilactobacillus reuteri strain (LRM2293), isolated from disease-resistant Min pigs, efficiently converted CDCA into ursodeoxycholic acid (UDCA). Both LRM2293 and UDCA significantly reduced PEDV replication in intestinal epithelial cells and ameliorated clinical symptoms in neonatal piglets. UDCA treatment increased type III interferon (IFN-λ3) expression, while pharmacological inhibition of TGR5 partially reversed both the antiviral effects of UDCA and IFN-λ3 induction. These findings support the potential involvement of TGR5-associated IFN-λ3 signaling in UDCA-mediated antiviral activity. In addition, UDCA preserved epithelial barrier integrity and attenuated oxidative stress, inflammatory responses, and endoplasmic reticulum stress in infected intestines. Collectively, our findings suggest that LRM2293-mediated bile acid remodeling is associated with enhanced resistance to PEDV infection. TGR5-associated IFN-λ3 signaling may represent one mechanism contributing to the antiviral effects of UDCA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, China.
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, 150030, China.
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, China. xieweichun_neau@163.com.
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, China. xiaonawang0319@163.com.
- Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin, 150030, China. xiaonawang0319@163.com.
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, 150030, China. tanglijie@neau.edu.cn.
Funding
- Postdoctoral Fellowship Program and China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Cite
APA
Sui, L., Xiang, Q., Kou, Y., Li, J., Jiang, Y., Cui, W., Xie, W., Wang, X., & Tang, L. (2026). A microbiota-bile acid-immune axis orchestrates intestinal antiviral defense: CDCA-to-UDCA biotransformation by Limosilactobacillus reuteri LRM2293 is associated with PEDV resistance. BMC Veterinary Research, 22(1). https://doi.org/10.1186/s12917-026-05928-4
Vancouver
Sui L, Xiang Q, Kou Y, Li J, Jiang Y, Cui W, et al. A microbiota-bile acid-immune axis orchestrates intestinal antiviral defense: CDCA-to-UDCA biotransformation by Limosilactobacillus reuteri LRM2293 is associated with PEDV resistance. BMC Veterinary Research. 2026;22(1). doi:10.1186/s12917-026-05928-4
BibTeX
@article{Sui2026,
author = {Sui, Ling and Xiang, Qing and Kou, Yuning and Li, Jiaxuan and Jiang, Yanping and Cui, Wen and Xie, Weichun and Wang, Xiaona and Tang, Lijie},
title = {A microbiota-bile acid-immune axis orchestrates intestinal antiviral defense: CDCA-to-UDCA biotransformation by Limosilactobacillus reuteri LRM2293 is associated with PEDV resistance},
journal = {BMC Veterinary Research},
year = {2026},
volume = {22},
number = {1},
doi = {10.1186/s12917-026-05928-4}
}
EUVIMED